A federal jury in Chicago has ordered the pharmaceutical company AbbVie Inc. to pay a Tennessee man more than $140 million as compensation for a heart attack he claimed was caused by his taking the testosterone-replacement drug AndroGel.

The  Oct. 5 verdict, first reported by Reuters, was delivered after a mistrial was declared in June when one of plaintiff Jeffrey Konrad’s lead attorneys became ill.